Literature DB >> 19577998

Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy.

Mounir W Z Basalus1, Marc J K Ankone, Gert K van Houwelingen, Frits H A F de Man, Clemens von Birgelen.   

Abstract

AIMS: To classify and quantify post-expansion irregularities in durable polymer-based coatings of drug-eluting stents (DES). METHODS AND
RESULTS: Taxus Liberté, Endeavor Sprint, Endeavor Resolute and Xience V DES (three samples of each) were explored by light microscopy and scanning electron microscopy (SEM) following expansion at 14 atm in water. Incidence and size of irregularities were measured during thorough quantitative examinations of a 360 SEM images. DES types examined showed a significant difference in the incidence of irregularities (p<0.0001; 6.6+/-4.2/image at 60-fold magnification) with typical patterns specific for each DES. All types showed areas with bare metal-aspects, but incidence, shape, and size differed largely: Sprint showed the largest areas. Cracks were only found in Sprint and Resolute, while wrinkles were seen exclusively in Taxus Liberté and Xience V (p<0.0001). The coating of each DES type showed some inhomogeneity of distribution, but the incidence differed (p<0.0001) and was least in Taxus Liberté, which, on the other hand, was the only DES that showed webbing with large bare-metal exposure.
CONCLUSIONS: The incidence and size of various coating irregularities on different types of DES varied widely. These data may be considered in ongoing discussions on the differences between DES and may serve as reference to compare novel DES.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577998     DOI: 10.4244/eijv5i1a24

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  14 in total

1.  Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.

Authors:  Byeong-Keuk Kim; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-25       Impact factor: 2.357

2.  Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation.

Authors:  Yuki Kakefuda; Akira Sato; Hiroaki Watabe; Hideaki Aihara; Hidetaka Nishina; Yuichi Noguchi; Tomoya Hoshi; Kazutaka Aonuma
Journal:  Heart Vessels       Date:  2015-07-29       Impact factor: 2.037

3.  Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology.

Authors:  Robert A Byrne; Shmuel Banai; Roisin Colleran; Antonio Colombo
Journal:  Interv Cardiol       Date:  2018-01

Review 4.  Stenting of coronary bifurcation lesions: a literature and technical review.

Authors:  Joo Myung Lee; Kyung Woo Park; Bon-Kwon Koo; Hyo-Soo Kim
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

5.  Changes to polymer surface of drug-eluting stents during balloon expansion.

Authors:  Scott J Denardo; Paul L Carpinone; David M Vock; Christopher D Batich; Carl J Pepine
Journal:  JAMA       Date:  2012-05-23       Impact factor: 56.272

6.  TWENTE Study: The Real-World Endeavor Resolute Versus Xience V Drug-Eluting Stent Study in Twente: study design, rationale and objectives.

Authors:  M W Z Basalus; K Tandjung; K G van Houwelingen; M G Stoel; F H A F de Man; J W Louwerenburg; S A M Saïd; G C M Linssen; M A W J Kleijne; J van der Palen; J Huisman; P M J Verhorst; C von Birgelen
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

7.  Evaluation of the effect of expansion and shear stress on a self-assembled endothelium mimicking nanomatrix coating for drug eluting stents in vitro and in vivo.

Authors:  Adinarayana Andukuri; IlJae Min; Patrick Hwang; Grant Alexander; Lauren E Marshall; Joel L Berry; Timothy M Wick; Yoon Ki Joung; Young-Sup Yoon; Brigitta C Brott; Dong Keun Han; Ho-Wook Jun
Journal:  Biofabrication       Date:  2014-07-22       Impact factor: 9.954

8.  Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).

Authors:  David E Kandzari; Pieter C Smits; Michael P Love; Ori Ben-Yehuda; Shmuel Banai; Simon D Robinson; Michael Jonas; Ran Kornowski; Rodrigo Bagur; Andres Iniguez; Haim Danenberg; Robert Feldman; Rajiv Jauhar; Harish Chandna; Manish Parikh; Gidon Y Perlman; Mercedes Balcells; Peter Markham; Melek Ozgu Ozan; Philippe Genereux; Elazer R Edelman; Martin B Leon; Gregg W Stone
Journal:  Circulation       Date:  2017-08-09       Impact factor: 29.690

9.  Meeting the Unmet - The Cre8 Polymer-free Drug-eluting Stents Technology: Proceedings of a satellite symposium held at EuroPCR on May 20th - 23rd 2014 in Paris.

Authors:  Katrina Mountfort; Didier Carrié; Marco Valgimigli; Gennaro Sardella; Shmuel Banai; Rafael Romaguera; Pieter Stella
Journal:  Interv Cardiol       Date:  2014-08

10.  Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement.

Authors:  Fumiyuki Otsuka; Masataka Nakano; Elena Ladich; Frank D Kolodgie; Renu Virmani
Journal:  Thrombosis       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.